Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuf Baran

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|October 18, 2012
Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancerMelis Kartal Yandım, Elif Apohan, Yusuf Baran
Hematology (Amsterdam, Netherlands)|March 23, 2011
Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cellsGeylani Can, Huseyin Atakan Ekiz, Yusuf Baran
Critical Reviews in Oncology/Hematology|May 27, 2011
Role of autophagy in the progression and suppression of leukemiasHuseyin Atakan Ekiz, Geylani Can, Yusuf Baran
Medical Oncology (Northwood, London, England)|January 19, 2008
Bisphosphonate treatment and radiotherapy in metastatic breast cancerA Ugur Ural, Ferit Avcu, Yusuf Baran
Hematology (Amsterdam, Netherlands)|September 14, 2007
Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cellsYusuf Baran, Ali Ugur Ural, Ufuk Gunduz
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 29, 2015
A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia CellsAysun Adan Gökbulut, Mustafa Yaşar, Yusuf Baran
Leukemia & Lymphoma|October 3, 2012
Changes in protein profiles of multiple myeloma cells in response to bortezomibTaylan Turan, Gülşah Sanlı-Mohamed, Yusuf Baran
Cancer Investigation|March 24, 2010
Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cellsYusuf Baran, Coskun Oztekin, Esen Yonca Bassoy
Nutrition and Cancer|April 19, 2011
Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cellsMelis Kartal, Guray Saydam, Fahri Sahin, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2011
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulationYusuf Baran, Jacek Bielawski, Ufuk Gunduz, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|October 18, 2012
Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancerMelis Kartal Yandım, Elif Apohan, Yusuf Baran
Hematology (Amsterdam, Netherlands)|March 23, 2011
Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cellsGeylani Can, Huseyin Atakan Ekiz, Yusuf Baran
Critical Reviews in Oncology/Hematology|May 27, 2011
Role of autophagy in the progression and suppression of leukemiasHuseyin Atakan Ekiz, Geylani Can, Yusuf Baran
Medical Oncology (Northwood, London, England)|January 19, 2008
Bisphosphonate treatment and radiotherapy in metastatic breast cancerA Ugur Ural, Ferit Avcu, Yusuf Baran
Hematology (Amsterdam, Netherlands)|September 14, 2007
Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cellsYusuf Baran, Ali Ugur Ural, Ufuk Gunduz
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 29, 2015
A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia CellsAysun Adan Gökbulut, Mustafa Yaşar, Yusuf Baran
Leukemia & Lymphoma|October 3, 2012
Changes in protein profiles of multiple myeloma cells in response to bortezomibTaylan Turan, Gülşah Sanlı-Mohamed, Yusuf Baran
Cancer Investigation|March 24, 2010
Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cellsYusuf Baran, Coskun Oztekin, Esen Yonca Bassoy
Nutrition and Cancer|April 19, 2011
Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cellsMelis Kartal, Guray Saydam, Fahri Sahin, et al.
Journal of Cancer Research and Clinical Oncology|August 12, 2011
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulationYusuf Baran, Jacek Bielawski, Ufuk Gunduz, et al.
Pageof 9